Home > News Shots > India

By Nidharshana | Jul 21, 2020 09:41 AM

The clinical trial of the indigenous coronavirus vaccine in India, had received approval for clinical trials. While the trials are being conducted at AIIMS Delhi, the hospital’s director on Monday, spoke to the reporters.

aiims humantrial launchdate of bharatbiotech covaxin coronavirus

He has revealed that the trial will have to undergo 3 phases at AIIMS. Initially, the test will be conducted on healthy volunteers between the age group 18-55. Around 375 people will be chosen for this phase. Within 4 or 6 weeks, they will analyse the volunteers. “In the first phase we see the safety of the vaccine which is of primary importance and the dose range is also calculated,” said Guleria, the Director of AIIMS.

He revealed that in the second phase, 750 volunteers within the age group of 12-65 will be studied. “We see how immunogenic it is and that is subsequently followed by phase 3, which involves a larger population to assess its efficacy and therapeutic benefit,” he said.

Further, when asked about the availability of a vaccine for public use, he said, “So, predicting exactly when the vaccine is going to be ready is a difficult business. But then say if everything works out ideally, then by the end of the year or early next year, we should be in a position to say that we can start manufacturing. But then there are lot of ifs and buts in that.

“We are very good in mass production. Even if a vaccine comes from any part of the world. India will be involved in its production because 60 per cent or more of the vaccines of the world are being made in India.”

“Launching of vaccine depends on its overall trial, we will have to check the effectiveness of the vaccine for at least 6 months. By the end of this year or early next year, there are chances that we will have a vaccine,” revealed Dr Sanjay Rai, head of community medicine at AIIMS.

அரசியல், விளையாட்டு, நாட்டுநடப்பு, குற்ற சம்பவங்கள், வர்த்தகம், தொழில்நுட்பம், சினிமா, வாழ்க்கை முறை என பலதரப்பட்ட சுவாரஸ்யமான செய்திகளை தமிழில் படிக்க இங்கு கிளிக் செய்யவும்      



This page contains news relating to various facts and events. The views are generally about current affiars and general topics in diversified areas such as political, international, national, and regional issues, sports, health, travel, lifestyle, technology and business. People having similar interets on the above topics will find this page useful. Aiims humantrial launchdate of bharatbiotech covaxin coronavirus | India News.